Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 4 Recruiting 3 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 665 Neoplasms 585 Colorectal Neoplasms 291 Carcinoma, Non-Small-Cell Lung 289 Prostatic Neoplasms 277 Lung Neoplasms 217 Melanoma 159 Multiple Myeloma 149 Neoplasm Metastasis 145 Head and Neck Neoplasms 143 Pancreatic Neoplasms 139 Ovarian Neoplasms 129 Carcinoma, Hepatocellular 126 Leukemia, Myeloid, Acute 121 Brain Neoplasms 111 Squamous Cell Carcinoma of Head and Neck 109 Colonic Neoplasms 109 Uterine Cervical Neoplasms 106 Stomach Neoplasms 102 Recurrence 101 Lymphoma 100 Glioblastoma 90 Lymphoma, Non-Hodgkin 82 Precursor Cell Lymphoblastic Leukemia-Lymphoma 78 Hematologic Neoplasms 78 Lymphoma, Follicular 77 Urinary Bladder Neoplasms 76 Parkinson Disease 4, Autosomal Dominant Lewy Body 74 Glioma 72 Sarcoma 70

Interventions

folfirinox 1 Oxaliplatin 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Cancer Metastatic × 1 year × Clear all

NCT04469556 2026-02-20

PASS-01

University Health Network, Toronto

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡